Abstract:Certain organic phosphorus esters produce sensorimotor axonopathy in man and other species. There is an excellent correlation between the capacity of an organophosphorus compound to produce axonopathy and its ability to inhibit brain neurotoxic esterase (NTE) in hens. Because NTE is present in peripheral lymphocytes of both hen and man, it has been suggested that the lymphocyte enzyme might be useful both in experimental and clinical situations as an indicator of exposure to organophosphorus compounds producin… Show more
“…Inhibition of brain NTE within hours of exposure to a neuropathic OP compound predicts the potential for OPIDN to appear in susceptible animal models (e.g., adult hens) after a delay of 1 to 3 wk. NTE has also been found in circulating lymphocytes and platelets (Bertoncin etal., 1985;Dudek & Richardson, 1982;Maroni & Bleecker, 1986;Richardson & Dudek, 1983), and lymphocyte NTE has been used or proposed for use as an accessible biomarker of animal and human exposure to neuropathic OP compounds (Johnson, 1990;Lotti, 1986;Lotti et al, 1983Lotti et al, , 1986Richardson & Dudek, 1983;Schwab & Richardson, 1986). Furthermore, lymphocyte NTE inhibition has been suggested as a predictor of OPIDN or an adjunct for its early diagnosis (Ehrich, 1996;Lotti, 1987;Mutch et al, 1992;Richardson & Dudek, 1983;Wilson & Henderson, 1992).…”
Section: And Between Brain and Blood (R = 997) The Results Suggest mentioning
confidence: 99%
“…Assay of lymphocyte NTE was shown to provide a reliable monitor of exposure to neuropathic OP compounds within 24h between exposure and measurement (Schwab & Richardson, 1986). To study the possibility of using blood NTE inhibition as a biochemical marker of neuropathic OP exposure and its correlation with brain NTE inhibition, two dosing experiments were carried out.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphocyte NTE Lymphocytes were isolated as described (Schwab & Richardson, 1986) by centrifuging in a Ficoll-Verografin density gradient. The lymphocyte fraction was resuspended in working buffer to make a concentration equivalent to 2 × 10 7 to 4 × 10 7 cells/ml and sonicated (10 s, power output 50 W) before NTE assay by the colorimetric method of Johnson (1977) using a 40-min incubation with PV.…”
Public Reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.
44379.1-LSNeuropathy target esterase (NTE) is the target for neuropathic organophosphorus compounds (OPs) that produce delayed neurotoxicity (OPIDN). Inhibition/aging of brain NTE predicts the potential for OPIDN in animal models. Lymphocyte NTE has also found use as a biomarker of human exposure to neuropathic OPs. Recently, a sensitive NTE biosensor was developed using a tyrosinase carbon-paste electrode for amperometric (Amp) detection of phenol produced by hydrolysis of the substrate, phenyl valerate. The I50 (20 min at 37 °C) for N,N'-di-2 propylphosphorodiamidofluoridate (mipafox) against hen lymphocyte NTE was 6.94 ± 0.28 •uM (Amp) and 6.02 ± 0.71 uM colorimetrically (Col). For O,O-di-1-propyl O-2,2-dichlorvinyl phosphate (PrDChVP), the I50 against hen brain NTE was 39 ± 8 nM (Amp) and 42 ± 2 nM (Col). I50 values (Amp) for PrDChVP against hen and human blood NTE were 66 ± 3 and 70 ± 14 nM, respectively. NTE activities in brain, lymphocytes, and blood were measured 24 h after dosing hens with PrDChVP. NTE inhibition was highly correlated between brain and lymphocyte (r = 0.994) and brain and blood (r = 0.997). Biosensor NTE assay for whole blood could serve as a biomarker of exposure to neuropathic OPs.12 (excluding cover forms) Biosensor, Delayed neurotoxicity, Mipafox, Organophosphorus compounds (OPs), Neuropathy target esterase (NTE).
“…Inhibition of brain NTE within hours of exposure to a neuropathic OP compound predicts the potential for OPIDN to appear in susceptible animal models (e.g., adult hens) after a delay of 1 to 3 wk. NTE has also been found in circulating lymphocytes and platelets (Bertoncin etal., 1985;Dudek & Richardson, 1982;Maroni & Bleecker, 1986;Richardson & Dudek, 1983), and lymphocyte NTE has been used or proposed for use as an accessible biomarker of animal and human exposure to neuropathic OP compounds (Johnson, 1990;Lotti, 1986;Lotti et al, 1983Lotti et al, , 1986Richardson & Dudek, 1983;Schwab & Richardson, 1986). Furthermore, lymphocyte NTE inhibition has been suggested as a predictor of OPIDN or an adjunct for its early diagnosis (Ehrich, 1996;Lotti, 1987;Mutch et al, 1992;Richardson & Dudek, 1983;Wilson & Henderson, 1992).…”
Section: And Between Brain and Blood (R = 997) The Results Suggest mentioning
confidence: 99%
“…Assay of lymphocyte NTE was shown to provide a reliable monitor of exposure to neuropathic OP compounds within 24h between exposure and measurement (Schwab & Richardson, 1986). To study the possibility of using blood NTE inhibition as a biochemical marker of neuropathic OP exposure and its correlation with brain NTE inhibition, two dosing experiments were carried out.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphocyte NTE Lymphocytes were isolated as described (Schwab & Richardson, 1986) by centrifuging in a Ficoll-Verografin density gradient. The lymphocyte fraction was resuspended in working buffer to make a concentration equivalent to 2 × 10 7 to 4 × 10 7 cells/ml and sonicated (10 s, power output 50 W) before NTE assay by the colorimetric method of Johnson (1977) using a 40-min incubation with PV.…”
Public Reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.
44379.1-LSNeuropathy target esterase (NTE) is the target for neuropathic organophosphorus compounds (OPs) that produce delayed neurotoxicity (OPIDN). Inhibition/aging of brain NTE predicts the potential for OPIDN in animal models. Lymphocyte NTE has also found use as a biomarker of human exposure to neuropathic OPs. Recently, a sensitive NTE biosensor was developed using a tyrosinase carbon-paste electrode for amperometric (Amp) detection of phenol produced by hydrolysis of the substrate, phenyl valerate. The I50 (20 min at 37 °C) for N,N'-di-2 propylphosphorodiamidofluoridate (mipafox) against hen lymphocyte NTE was 6.94 ± 0.28 •uM (Amp) and 6.02 ± 0.71 uM colorimetrically (Col). For O,O-di-1-propyl O-2,2-dichlorvinyl phosphate (PrDChVP), the I50 against hen brain NTE was 39 ± 8 nM (Amp) and 42 ± 2 nM (Col). I50 values (Amp) for PrDChVP against hen and human blood NTE were 66 ± 3 and 70 ± 14 nM, respectively. NTE activities in brain, lymphocytes, and blood were measured 24 h after dosing hens with PrDChVP. NTE inhibition was highly correlated between brain and lymphocyte (r = 0.994) and brain and blood (r = 0.997). Biosensor NTE assay for whole blood could serve as a biomarker of exposure to neuropathic OPs.12 (excluding cover forms) Biosensor, Delayed neurotoxicity, Mipafox, Organophosphorus compounds (OPs), Neuropathy target esterase (NTE).
“…Animal studies have been used to test correlations of inhibition in lymphocytes with that in brain (Makhaeva et al, 2003(Makhaeva et al, , 2007Richardson and Dudek, 1983;Richardson et al, 1993a,b;Schwab and Richardson, 1986). Lymphocyte NTE activity has been characterized in human populations (Bertoncin et al, 1985;Maroni and Bleecker, 1986) and used to monitor occupational exposures to potentially neuropathic OP compounds (Lotti et al, 1983(Lotti et al, , 1986McConnell et al, 1999).…”
“…A more detailed time-course study indicated a strong correlation between the levels of muscarinic receptors in brain areas and lymphocytes during the period of exposure (65 (81,82). Within 24 hr after acute exposure, there is a good correlation between lymphocyte and brain NTE in the hen, which is the species of choice for OPIDP studies (83). Measurement of lymphocyte NTE has been suggested as a potential biomarker to monitor for organophosphate-induced polyneuropathy (84).…”
There is an increasing interest in the development and validation of biomarkers for use in biochemical/molecular epidemiological studies. Though the area of neurotoxicology has received much attention in the past several years, it still lags behind with regard to the development of biomarkers, particularly those of health effects and susceptibility. This review discusses several aspects of biomarker research as it relates to neurotoxic compounds and focuses on selected agents (organophosphorus insecticides, styrene, n-hexane, carbon disulfide, acrylamide), which have been the subject of a number of investigations in animals and humans. While traditional biomonitoring approaches and novel techniques (e.g., hemoglobin adducts) provide several measurements for monitoring exposure to neurotoxic chemicals, potential markers of genetic susceptibility have been seldom investigated in a neurotoxicology context. Furthermore, the complexity of the nervous system, together with the multiplicity of end points and the limited knowledge of the exact mechanism(s) of action of neurotoxicants, has led to only limited advancements in the development of biomarkers for neurotoxic effects. Significant progress in this area will depend upon an increased understanding of the cellular, biochemical, and molecular targets directly involved in neurotoxicity. Environ Health Perspect 1 04(Suppl 1): 55-67 (1996)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.